trial

Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients

NCTId NCT01300637
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 60 (estimated)
Sponsored by Taipei Medical University Shuang Ho Hospital
Primary completion 2009-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2008-11
Primary completion
2009-04
Eligibility
ALL · 20 Years · 65 Years

Interventions & indications

Drugs
Metformin

Sponsors

Taipei Medical University Shuang Ho HospitalLead Sponsor
National Science and Technology Council, TaiwanCollaborator

Investigators

1
Chun-Hsin Chen, MDPrincipal Investigator

Sites

1 total
Taipei, Taiwan

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2009-04
Status
UNKNOWN
relationships
The graph out of here
drug
Metformin
drug
lead_sponsor
Taipei Medical University Shuang Ho Hospital
company
collaborator
National Science and Technology Council, Taiwan
company
indication
Obesity
indication
Metabolic Syndrome
indication
Schizophrenia
indication
investigator
Chun-Hsin Chen, MD
person